Suppr超能文献

竞争性和非竞争性NMDA受体拮抗剂对大鼠中7-OH-DPAT和喹吡罗诱导的行为反应的影响。

Effects of competitive and non-competitive NMDA receptor antagonists on behavioral responses induced by 7-OH-DPAT and quinpirole in rats.

作者信息

Dall'olio R, Rimondini R, Gandolfi O

机构信息

Department of Pharmacology, University of Bologna, Via Irnerio 48, Bologna, I-40126, Italy.

出版信息

Pharmacol Res. 1997 Sep;36(3):203-9. doi: 10.1006/phrs.1997.0223.

Abstract

The administration of dizocilpine (0.06 mg kg-1), but not of CGP 43487 (0.75 mg kg-1), counteracted the hypolocomotion induced in the rat by low doses (5-80 microg kg-1) of the putative D3 dopamine agonist 7-OH-DPAT. Both NMDA antagonists did not change the reduced locomotion due to the administration of low doses (12.5-50 microg kg-1) of the D2 agonist quinpirole. In spite of the lack of effect of either NMDA receptor antagonist on D2 or D3 recognition sites, as shown by our radioligand binding studies, the behavioural findings suggest that the non-competitive, but not the competitive, NMDA receptor antagonist physiologically antagonizes dopamine D3 receptor mediated mechanisms. Both NMDA receptor antagonists failed to modify the hyperlocomotion induced by high doses (160 and 320 microg kg-1) of 7-OH-DPAT, whereas they inhibited the same behavioural response produced by high doses of quinpirole (150 and 300 microg kg-1). The different effect of the NMDA receptor antagonists on the behavioural responses induced by the dopaminergic agonists could be explained by the different activity of 7-OH-DPAT and quinpirole on D3/D2 receptors. Either dizocilpine or CGP 43487 induced stereotyped responses to high doses of 7-OH-DPAT. This suggests that both NMDA receptor antagonists could potentiate dopaminergic function in the striatum, a region critically involved in the generation of stereotyped behaviour.

摘要

给予地佐环平(0.06毫克/千克)可对抗低剂量(5 - 80微克/千克)假定的D3多巴胺激动剂7 - OH - DPAT诱导的大鼠运动减少,但给予CGP 43487(0.75毫克/千克)则无此作用。两种NMDA拮抗剂均未改变因给予低剂量(12.5 - 50微克/千克)D2激动剂喹吡罗而导致的运动减少。尽管如我们的放射性配体结合研究所示,两种NMDA受体拮抗剂对D2或D3识别位点均无影响,但行为学研究结果表明,非竞争性而非竞争性NMDA受体拮抗剂在生理上可拮抗多巴胺D3受体介导的机制。两种NMDA受体拮抗剂均未能改变高剂量(160和320微克/千克)7 - OH - DPAT诱导的运动亢进,而它们抑制了高剂量喹吡罗(150和300微克/千克)产生的相同行为反应。NMDA受体拮抗剂对多巴胺能激动剂诱导的行为反应的不同作用,可通过7 - OH - DPAT和喹吡罗对D3/D2受体的不同活性来解释。地佐环平或CGP 43487对高剂量7 - OH - DPAT均诱导了刻板反应。这表明两种NMDA受体拮抗剂均可增强纹状体中的多巴胺能功能,纹状体是一个在刻板行为产生中起关键作用的区域。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验